Absolute oral bioavailability and pharmacokinetics of canagliflozin: A microdose study in healthy participants

By  

Clinical Pharmacology In Drug Development, Vol. 4, Iss. 4, 2015-07 ,pp. : 295-304

John Wiley & Sons Inc

Access to resources Recommend Favorite

High absolute bioavailability of methylene blue given as an aqueous oral formulation

By Walter-Sack Ingeborg   Rengelshausen Jens   Oberwittler Heike   Burhenne Juergen   Mueller Olaf   Meissner Peter   Mikus Gerd  

European Journal of Clinical Pharmacology, Vol. 65, Iss. 2, 2009-02 ,pp. : 179-189

Springer Publishing Company

Access to resources Recommend Favorite

The Absolute Oral Bioavailability and Population-Based Pharmacokinetic Modelling of a Novel Dipeptidylpeptidase-IV Inhibitor, Vildagliptin, in Healthy Volunteers

By He Yan-Ling  

Clinical Pharmacokinetics, Vol. 46, Iss. 9, 2007-01 ,pp. : 787-802

Adis International

Access to resources Recommend Favorite

Pharmacokinetics and Pharmacodynamics of Single Rising Intravenous Doses (0.5 mg-10 mg) and Determination of Absolute Bioavailability of the Dipeptidyl Peptidase-4 Inhibitor Linagliptin (BI 1356) in Healthy Male Subjects

By Retlich Silke  

Clinical Pharmacokinetics, Vol. 49, Iss. 12, 2010-12 ,pp. : 829-840

Adis International

Access to resources Recommend Favorite

Enantioselective pharmacokinetics and bioavailability of different racemic -lipoic acid formulations in healthy volunteers

By Dar A.   Shaviv N.J.   Hermann R.   Niebch G.   Borbe H.O.   Fieger-Buschges H.   Ruus P.   Nowak H.   Riethmuller-Winzen H.   Peukert M.   Blume H.  

European Journal of Pharmaceutical Sciences, Vol. 4, Iss. 3, 1996-05 ,pp. : 167-174

Elsevier

Access to resources Recommend Favorite